FR2826012B1 - Complexes moleculaires brca1/accalpha, applications diagnostiques et therapeutiques - Google Patents

Complexes moleculaires brca1/accalpha, applications diagnostiques et therapeutiques

Info

Publication number
FR2826012B1
FR2826012B1 FR0107740A FR0107740A FR2826012B1 FR 2826012 B1 FR2826012 B1 FR 2826012B1 FR 0107740 A FR0107740 A FR 0107740A FR 0107740 A FR0107740 A FR 0107740A FR 2826012 B1 FR2826012 B1 FR 2826012B1
Authority
FR
France
Prior art keywords
accalpha
brca1
diagnostic
therapeutic applications
molecular complexes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0107740A
Other languages
English (en)
Other versions
FR2826012A1 (fr
Inventor
Venezia Nicole Lucienne Dalla
Clemence Marie Magnard
Gilbert M Lenoir
Erard Olga Sinilnikova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0107740A priority Critical patent/FR2826012B1/fr
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to EP02745520A priority patent/EP1430081A2/fr
Priority to PCT/FR2002/002015 priority patent/WO2002100896A2/fr
Priority to AU2002327870A priority patent/AU2002327870A1/en
Priority to AU2002317247A priority patent/AU2002317247A1/en
Priority to US10/480,434 priority patent/US20060105403A1/en
Priority to PCT/FR2002/002016 priority patent/WO2002100897A2/fr
Priority to CA002450663A priority patent/CA2450663A1/fr
Publication of FR2826012A1 publication Critical patent/FR2826012A1/fr
Application granted granted Critical
Publication of FR2826012B1 publication Critical patent/FR2826012B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
FR0107740A 2001-06-13 2001-06-13 Complexes moleculaires brca1/accalpha, applications diagnostiques et therapeutiques Expired - Fee Related FR2826012B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR0107740A FR2826012B1 (fr) 2001-06-13 2001-06-13 Complexes moleculaires brca1/accalpha, applications diagnostiques et therapeutiques
PCT/FR2002/002015 WO2002100896A2 (fr) 2001-06-13 2002-06-12 Methode de diagnostic d'une susceptibilite au cancer associe a des polymorphismes du gene d'acetyl-coenzyme a-carboxylase - alpha (acc-alpha)
AU2002327870A AU2002327870A1 (en) 2001-06-13 2002-06-12 Method for diagnosing cancer susceptibility
AU2002317247A AU2002317247A1 (en) 2001-06-13 2002-06-12 Brca1/acc alpha molecular complexes, diagnostic and therapeutic applications
EP02745520A EP1430081A2 (fr) 2001-06-13 2002-06-12 Complexes moleculaires brca1/acc alpha, applications diagnostiques et therapeutiques
US10/480,434 US20060105403A1 (en) 2001-06-13 2002-06-12 Braca1/acc alpha molecular complexes, diagnostic and therapeutic applications
PCT/FR2002/002016 WO2002100897A2 (fr) 2001-06-13 2002-06-12 Complexes moleculaires brca1/acc alpha, applications diagnostiques et therapeutiques
CA002450663A CA2450663A1 (fr) 2001-06-13 2002-06-12 Complexes moleculaires brca1/acc alpha, applications diagnostiques et therapeutiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0107740A FR2826012B1 (fr) 2001-06-13 2001-06-13 Complexes moleculaires brca1/accalpha, applications diagnostiques et therapeutiques

Publications (2)

Publication Number Publication Date
FR2826012A1 FR2826012A1 (fr) 2002-12-20
FR2826012B1 true FR2826012B1 (fr) 2003-09-26

Family

ID=8864269

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0107740A Expired - Fee Related FR2826012B1 (fr) 2001-06-13 2001-06-13 Complexes moleculaires brca1/accalpha, applications diagnostiques et therapeutiques

Country Status (1)

Country Link
FR (1) FR2826012B1 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996005307A2 (fr) * 1994-08-12 1996-02-22 Myriad Genetics, Inc. Gene de susceptibilite au cancer des ovaires et du sein lie a 17q

Also Published As

Publication number Publication date
FR2826012A1 (fr) 2002-12-20

Similar Documents

Publication Publication Date Title
DE60225431D1 (de) Dialysekatheter
DE60204686D1 (de) 3-arylsubstituierte zyklopentadienyl-metal-komplexe und polymerisationsverfahren
DE60220315D1 (de) Medizinisches verbindungsstück
DE60208177D1 (de) Propylenpolymerzusammensetzung, formkörper und polyolefincopolymer
BR0014930B1 (pt) cÂnula.
DE60237823D1 (de) Medizinisches behandlungsinstrument
NO20012170D0 (no) Selvstendig, transportabel blodbehandlingsinnretning
DE60110198D1 (de) Medizinisches Kommunikationssystem
NO20041315L (no) Medikamentavleveringssystem
EE200300311A (et) Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
NO20033549D0 (no) Terapeutiske bindingsmolekyler
AR028476A1 (es) Tratamiento del cancer
DE69930258D1 (de) Medizinischer Konnektor
NO20005179D0 (no) Medikament behandling
DE50209245D1 (de) Neuroprotektives medikament
DK1202996T3 (da) Titanforbindelser, fremstilling og anvendelse heraf
DE60032884D1 (de) Blutbehandlungssystem
DE60220220D1 (de) Blutbehandlungssystem
DE50207147D1 (de) Endoskopischer Katheter
BR0112264B1 (pt) dispositivo de tratamento de sangue.
NO20042693L (no) Kateterpreparat og anvendelser derav
DE60227963D1 (de) Behandlungssystem
FR2819508B1 (fr) Derives de 2-arylimino-2, 3-dihydorthiazoles, leurs procedes de preparation et leur utilisation therapeutiques
FR2826012B1 (fr) Complexes moleculaires brca1/accalpha, applications diagnostiques et therapeutiques
DK1364652T3 (da) Lægemidler mod lungecancer

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20070228